68 related articles for article (PubMed ID: 22097930)
1. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy.
Espírito Santo J; Ladeirinha A; Alarcão A; Strelet E; Reis M; Santos R; Carvalho L
Med Oncol; 2023 Oct; 40(12):340. PubMed ID: 37882867
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Locoregional Therapy May Relate with Stemness and Distinct Transitions Between Epithelial and Mesenchymal States in Hepatocellular Carcinoma.
Espírito Santo J; Ladeirinha A; Alarcão A; Strelet E; Reis M; Santos R; Carvalho L
J Clin Exp Hepatol; 2024; 14(1):101268. PubMed ID: 38076372
[TBL] [Abstract][Full Text] [Related]
4. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
5. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
6. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
[TBL] [Abstract][Full Text] [Related]
8. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
Taouli B; Hoshida Y; Kakite S; Chen X; Tan PS; Sun X; Kihira S; Kojima K; Toffanin S; Fiel MI; Hirschfield H; Wagner M; Llovet JM
Eur Radiol; 2017 Nov; 27(11):4472-4481. PubMed ID: 28439654
[TBL] [Abstract][Full Text] [Related]
9. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
Front Oncol; 2021; 11():672126. PubMed ID: 34476208
[TBL] [Abstract][Full Text] [Related]
10. Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers.
Shousha HI; Fouad R; Elbaz TM; Sabry D; Mahmoud Nabeel M; Hosni Abdelmaksoud A; Mahmoud Elsharkawy A; Soliman ZA; Habib G; Abdelaziz AO
Arab J Gastroenterol; 2020 Jun; 21(2):95-101. PubMed ID: 32439234
[TBL] [Abstract][Full Text] [Related]
11. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
Hectors SJ; Lewis S; Besa C; King MJ; Said D; Putra J; Ward S; Higashi T; Thung S; Yao S; Laface I; Schwartz M; Gnjatic S; Merad M; Hoshida Y; Taouli B
Eur Radiol; 2020 Jul; 30(7):3759-3769. PubMed ID: 32086577
[TBL] [Abstract][Full Text] [Related]
12. The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection.
Zhang L; Kuang S; Chen J; Zhang Y; Zhao B; Peng H; Xiao Y; Fowler K; Wang J; Sirlin CB
Front Oncol; 2019; 9():1336. PubMed ID: 31850221
[No Abstract] [Full Text] [Related]
13. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
[TBL] [Abstract][Full Text] [Related]
14. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.
Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
Eur J Radiol; 2019 Apr; 113():7-14. PubMed ID: 30927962
[TBL] [Abstract][Full Text] [Related]
15. Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.
Yoneda N; Matsui O; Kobayashi S; Kitao A; Kozaka K; Inoue D; Yoshida K; Minami T; Koda W; Gabata T
Jpn J Radiol; 2019 Mar; 37(3):191-208. PubMed ID: 30712167
[TBL] [Abstract][Full Text] [Related]
16. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
17. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
Chernyak V; Fowler KJ; Kamaya A; Kielar AZ; Elsayes KM; Bashir MR; Kono Y; Do RK; Mitchell DG; Singal AG; Tang A; Sirlin CB
Radiology; 2018 Dec; 289(3):816-830. PubMed ID: 30251931
[TBL] [Abstract][Full Text] [Related]
18. MRI features of hepatocellular carcinoma related to biologic behavior.
Cho ES; Choi JY
Korean J Radiol; 2015; 16(3):449-64. PubMed ID: 25995679
[TBL] [Abstract][Full Text] [Related]
19. Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection.
An C; Kim DW; Park YN; Chung YE; Rhee H; Kim MJ
Radiology; 2015 Aug; 276(2):433-43. PubMed ID: 25751229
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.
Tabrizian P; Jibara G; Shrager B; Schwartz M; Roayaie S
Ann Surg; 2015 May; 261(5):947-55. PubMed ID: 25010665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
